These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 11922251

  • 1. Isoniazid chemoprophylaxis in Indian scenario: need for a practical approach?
    Dixit R, Joshi N, Jain NK.
    J Assoc Physicians India; 2002 Mar; 50():459. PubMed ID: 11922251
    [No Abstract] [Full Text] [Related]

  • 2. Chemoprophylaxis of tuberculosis.
    Meade GM.
    GP; 1968 Sep; 38(3):113-9. PubMed ID: 5303085
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Detection of tuberculosis in children of new risk groups and efficacy of chemoprophylaxis].
    Mitinskaia LA, Elufimova VF, Iukhimenko NV, Demeshko ND, Altynova MP, Kufakova GA.
    Probl Tuberk; 1996 Sep; (6):33-5. PubMed ID: 9019765
    [Abstract] [Full Text] [Related]

  • 5. Exposure to open tuberculosis on a neonatal unit.
    Isaacs D, Jones CA, Dalton D, Cripps T, Vidler L, Rochefort M, Bide E, Banner P, Crawford H.
    J Paediatr Child Health; 2006 Sep; 42(9):557-9. PubMed ID: 16925546
    [Abstract] [Full Text] [Related]

  • 6. Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime.
    Nolan CM.
    Am J Respir Crit Care Med; 2003 Aug 15; 168(4):412-3. PubMed ID: 12912731
    [No Abstract] [Full Text] [Related]

  • 7. A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial.
    Tsai TF, Chiu HY, Song M, Chan D.
    Br J Dermatol; 2013 Feb 15; 168(2):444-6. PubMed ID: 22816505
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Another step on the path to better TB therapies.
    Vernon A, Burman W, Horsburgh CR.
    Int J Tuberc Lung Dis; 2002 Jan 15; 6(1):1-2. PubMed ID: 11931394
    [No Abstract] [Full Text] [Related]

  • 11. Screening childhood contacts of patients with smear-positive pulmonary tuberculosis in Malawi.
    Claessens NJ, Gausi FF, Meijnen S, Weismuller MM, Salaniponi FM, Harries AD.
    Int J Tuberc Lung Dis; 2002 Apr 15; 6(4):362-4. PubMed ID: 11936747
    [Abstract] [Full Text] [Related]

  • 12. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR, Agarwal SK, Shah KV.
    Int J Tuberc Lung Dis; 2002 Dec 15; 6(12):1098-101. PubMed ID: 12546118
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemoprophylaxis in tuberculosis.
    Payne RF.
    J Med Assoc Ga; 1968 Sep 15; 57(9):411-5. PubMed ID: 5679186
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The present situation of antitubercular chemoprophylaxis in Italy and in the world].
    Omodei Zorini A.
    Lotta Tuberc; 1966 Sep 15; 36(3):77-87. PubMed ID: 5226979
    [No Abstract] [Full Text] [Related]

  • 20. Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations.
    Smirnov GA.
    Fed Proc Transl Suppl; 1966 Sep 15; 25(1):72-6. PubMed ID: 5322111
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.